Longitudinal Change in CSF Tau and Aβ Biomarkers for Up to 48 Months in ADNI

Acta Neuropathologica - Germany
doi 10.1007/s00401-013-1151-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Genome-Wide Association and Interaction Studies of CSF T-Tau/Aβ 42 Ratio in ADNI Cohort

Neurobiology of Aging
AgingGerontologyDevelopmental BiologyGeriatricsNeuroscienceNeurology
2017English

Prediction and Longitudinal Study of CSF Biomarkers in Mild Cognitive Impairment

Neurobiology of Aging
AgingGerontologyDevelopmental BiologyGeriatricsNeuroscienceNeurology
2009English

Amyloid Imaging and CSF Biomarkers in Predicting Cognitive Impairment Up to 7.5 Years Later

Neurology
Neurology
2013English

Aβ Levels in the Jugular Vein and High Molecular Weight Aβ Oligomer Levels in CSF Can Be Used as Biomarkers to Indicate the Anti-Amyloid Effect of IVIg for Alzheimer’s Disease

PLoS ONE
Multidisciplinary
2017English

Qualification of the Analytical and Clinical Performance of CSF Biomarker Analyses in ADNI

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2011English

Neurological Assessment and Its Relationship to CSF Biomarkers in Amateur Boxers

PLoS ONE
Multidisciplinary
2014English

Targeting Aβ and Tau in Alzheimer's Disease, an Early Interim Report

Experimental Neurology
Developmental NeuroscienceNeurology
2010English

Tau Transgenic Mice as Models for Cerebrospinal Fluid Tau Biomarkers

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2011English

Tau Passive Immunization Inhibits Not Only Tau but Also Aβ Pathology

Alzheimer's Research and Therapy
NeurologyCognitive Neuroscience
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy